⌘K

Login Start Free

Home/Filings/4/0001104659-25-043509

4//SEC Filing

MONAHAN JOHN J 4

Accession 0001104659-25-043509

CIK 0000894158other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:01 PM ET

Size

5.8 KB

Accession

0001104659-25-043509

Insider Transaction Report

Form 4

Period: 2025-04-29

Theriva Biologics, Inc.TOVX

Director

Transactions

Award
Stock Options (right to buy)
2025-04-29+25,000→ 25,000 total
Exercise: $1.41From: 2025-05-01Exp: 2032-04-29→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]These stock options vest pro rata on a monthly basis over 12 months.

Documents

1 file

4
tm2513725-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Theriva Biologics, Inc.

CIK 0000894158

Entity typeother

Related Parties

1

filerCIK 0001257825

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 4:01 PM ET
Size: 5.8 KB

View on SEC.gov